Question 1

What is NovoCure's other payables, lease liabilities and accrued expenses?

Accepted Answer

NovoCure (NVCR) reported other payables, lease liabilities and accrued expenses of $89.98M in Q2 2026.

Question 2

How has NovoCure's other payables, lease liabilities and accrued expenses changed year-over-year?

Accepted Answer

NovoCure's other payables, lease liabilities and accrued expenses increased by 4.4% year-over-year, from $86.17M to $89.98M.

Question 3

What is the long-term trend for NovoCure's other payables, lease liabilities and accrued expenses?

Accepted Answer

Over 5 years (2020 to 2025), NovoCure's other payables, lease liabilities and accrued expenses has grown at a 11.0% compound annual growth rate (CAGR), from $59.97M to $101M.

Question 4

What does other payables, lease liabilities and accrued expenses mean?

Accepted Answer

This captures miscellaneous short-term obligations including operational lease commitments and various accrued expenses not categorized as trade payables. It provides insight into the company's near-term cash outflow requirements related to ongoing business operations. High levels of these liabilities relative to cash flow may indicate pressure on working capital.

Line item	June 30,2026	December 31, 2025
LIABILITIES AND SHAREHOLDERS' EQUITY
CURRENT LIABILITIES:
Trade payables	130,729	122,231
Other payables, lease liabilities and accrued expenses	89,981	100,997
Total current liabilities	220,710	223,228
LONG-TERM LIABILITIES:
Senior secured credit facility, net	195,891	195,047
Long-term leases	37,529	41,647

Other payables, lease liabilities and accrued expenses at other companies

Other financials

Income statement

Balance sheet

Cash flow

Valuation

Profitability

Returns & leverage

Where this comes from

FAQ

Ask your AI about NovoCure's other payables, lease liabilities and accrued expenses.

NovoCure NVCR Other payables, lease liabilities and accrued expenses